A recent systematic review by Law et al. [23] analyzed 63 studies regarding the effects of immunomodulators on postoperative complications after surgery for inflammatory bowel disease and found an increased risk for abdominal sepsis for anti-TNF medication and corticosteroids, whereas the risk was not increased for other immune-modulators and anti-integrins [23]. The gene discussed is TNF; the disease is inflammatory bowel disease.